Evaluation of Levetiracetam's Effectiveness and Tolerability for Treating Epilepsy in Older Adults

This prospective interventional study was conducted between 2023 and 2025 at the Department of Neurology of Bouali Sina Hospital. Consecutive elderly patients presenting with epilepsy were screened for eligibility. The diagnosis of epilepsy was confirmed by the treating neurologist. The patients underwent treatment with levetiracetam. Primary and secondary outcomes were investigated as was explained before.

NCT Number	NCT07422233
Lead Sponsor	Nasim Tabrizi
Conditions	Epilepsy, Elderly
Enrollment	137 participants
Start Date	2023-09-13
Primary Completion	2025-12-31 (estimated)
Study Completion	2026-01-20 (estimated)
Updated on ClinicalTrials.gov	2026-02-19